51³Ô¹ÏÍø

Director of neurological research Dr. Lennart Mucke (middle) talks with Sumihiro Maeda, PhD (left) at the Gladstone Institutes in San Francisco, California, on Monday, November 18, 2013. Dr. Mucke has been studying a protein called beta amyloid, the prima

Director of neurological research Dr. Lennart Mucke (middle) talks with Sumihiro Maeda, PhD (left) at the Gladstone Institutes in San Francisco, California, on Monday, November 18, 2013. Dr. Mucke has been studying a protein called beta amyloid, the primary target of Alzheimer's research. (Photo By Liz Hafalia/The San Francisco Chronicle via Getty Images)
Director of neurological research Dr. Lennart Mucke (middle) talks with Sumihiro Maeda, PhD (left) at the Gladstone Institutes in San Francisco, California, on Monday, November 18, 2013. Dr. Mucke has been studying a protein called beta amyloid, the primary target of Alzheimer's research. (Photo By Liz Hafalia/The San Francisco Chronicle via Getty Images)
Director of neurological research Dr. Lennart Mucke (middle) talks with Sumihiro Maeda, PhD (left) at the Gladstone Institutes in San Francisco, California, on Monday, November 18, 2013. Dr. Mucke has been studying a protein called beta amyloid, the prima
PURCHASE A LICENSE
How can I use this image?
€300.00
EUR
Getty ImagesDirector of neurological research Dr. Lennart Mucke (middle) talks..., News PhotoDirector of neurological research Dr. Lennart Mucke (middle) talks..., News PhotoDirector of neurological research Dr. Lennart Mucke (middle) talks... Get premium, high resolution news photos at Getty ImagesProduct #:1321624778
€475€115
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.
Editorial #:
1321624778
Collection:
Hearst Newspapers
Date created:
November 18, 2013
Upload date:
License type:
Release info:
Not released.ÌýMore information
Source:
Hearst Newspapers
Object name:
health20alzheimers_ph3
Max file size:
3750 x 2746 px (12.50 x 9.15 in) - 300 dpi - 5 MB